FDA Alert Regarding Lupus Medication: a Hospital for Special Surgery Rheumatology Perspective
Progressive Multifocal Leukoencephalopathy (PML) in Patients Treated with Mycophenolate mofetil (CellCept)
Monday, April 21, 2008
On April 10, 2008, the FDA released a safety alert concerning a possible relationship between CellCept (mycophenolate mofetil) and a devastating neurological disease known as progressive multifocal leukoencephalopathy (PML).
On the go?
Text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and Data Rates May Apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms